Почетна › Акутна лимфобластна леукемија › Калифорнија
Клинички испитувања за Акутна лимфобластна леукемија во Калифорнија
40 студии за Акутна лимфобластна леукемија бараат учесници на локации во Калифорнија.
Градови во Калифорнија
- Baldwin Park21 студија
- Los Angeles14 студии
- Mountain View13 студии
- San Diego6 студии
- Orange5 студии
- San Francisco5 студии
- Sacramento3 студии
- San Bernardino3 студии
Официјален текст на студијата (англиски)
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Children's Hospital of Los Angeles, Los Angeles
Се регрутира
Возраст од 1 до 25 · Сите полови · Ажурирано 5.10.2026 · NCT05621291Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- и уште 20
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- City of Hope, Duarte
- UC Davis, Sacramento
- Stanford Health Care, Stanford
Се регрутираФаза 1
Возраст од 12 до 78 · Сите полови · Ажурирано 29.9.2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- City of Hope, Duarte
- Children's Hospital Los Angeles, Los Angeles
Се регрутираФаза 2
6 Months · Сите полови · Ажурирано 28.9.2026 · NCT06514794Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
- Stanford University, Palo Alto
Се регрутираФаза 1
Возраст од 1 до 25 · Сите полови · Ажурирано 1.9.2026 · NCT06408194The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- и уште 8
Се регрутираФаза 1/2
До возраст 22 · Сите полови · Ажурирано 25.8.2026 · NCT04726241Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Lucille Packard Children's Hospital of Stanford University, Palo Alto
Се регрутираФаза 1
18 Months – 39 Years · Сите полови · Ажурирано 21.8.2026 · NCT07573111A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte
- Stanford University (Data Collection AND Specimen Analysis), Stanford
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 20.8.2026 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Stanford University, Palo Alto
Се регрутираФаза 1/2
Возраст 1 и постари · Сите полови · Ажурирано 19.8.2026 · NCT07070219Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
Се регрутираФаза 2
Возраст од 7 до 25 · Сите полови · Ажурирано 19.8.2026 · NCT05082519Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Memorial Health Service, Fountain Valley
- University of California Los Angeles, Los Angeles
Се регрутираНабљудувачка студија
1 Day – 17 Years · Сите полови · Ажурирано 14.8.2026 · NCT06274788Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Cedars-Sinai Medical Center, Los Angeles
Се регрутираФаза 1
Возраст од 18 до 85 · Сите полови · Ажурирано 10.8.2026 · NCT05887167225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
Се регрутираФаза 1
Возраст од 18 до 70 · Сите полови · Ажурирано 31.7.2026 · NCT06287944A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
Се регрутираФаза 1Добредојдени се здрави волонтери
Возраст од 18 до 75 · Сите полови · Ажурирано 28.7.2026 · NCT07020533Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Rady Children's Hospital, San Diego
Се регрутираФаза 4
Возраст од 1 до 18 · Сите полови · Ажурирано 14.7.2026 · NCT06289673Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Duarte
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 13.7.2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- City of Hope, Duarte
- Children's Hospital of Los Angeles, Glendale
- Scripps Green Hospital, La Jolla
- и уште 8
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 6.7.2026 · NCT01351545Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- City of Hope Medical Center, Duarte
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 29.6.2026 · NCT06815003Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Stanford University, Palo Alto
Се регрутираФаза 1
Возраст од 18 до 70 · Сите полови · Ажурирано 23.6.2026 · NCT06551584A Study of Revumenib and Mezigdomide in People With Leukemia
- City of Hope Cancer Center (Data collection only), Duarte
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 22.6.2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Children's Hospital Los Angeles, Los Angeles
- Valley Children's Hospital, Madera
- Children's Hospital of Orange County, Orange
- и уште 2
Се регрутираФаза 1/2
До возраст 1 · Сите полови · Ажурирано 3.6.2026 · NCT05848687Pharmacogenomics of Asparaginase Induced Hepatotoxicity
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 1.6.2026 · NCT03568266Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- City of Hope Comprehensive Cancer Center, Duarte
- Kaiser Permanente-Oakland, Oakland
- Lucile Packard Children's Hospital Stanford University, Palo Alto
- и уште 1
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 18.5.2026 · NCT01790152A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1062, Duarte
- Ascentage Investigative Site #1134, Los Angeles
- Ascentage Investigative Site #1059, Los Angeles
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.4.2026 · NCT06051409Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
Се регрутираФаза 1Добредојдени се здрави волонтери
Возраст 60 и постари · Сите полови · Ажурирано 29.4.2026 · NCT06195891Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
- City of Hope Medical Center, Duarte
Се регрутираРана фаза 1
Возраст 18 и постари · Сите полови · Ажурирано 27.4.2026 · NCT06735690A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Hoag Family Cancer Center, Newport Beach
- Stanford University, Palo Alto
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 24.3.2026 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- City of Hope, Duarte
- Stanford, Palo Alto
Се регрутираФаза 2
Возраст од 18 до 66 · Сите полови · Ажурирано 17.3.2026 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- City of Hope Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- и уште 1
Се регрутираФаза 2
Возраст од 18 до 54 · Сите полови · Ажурирано 17.3.2026 · NCT06918431Venetoclax Basket Trial for High Risk Hematologic Malignancies
- University of California San Francisco-Benioff Children's Hospital, San Francisco
Се регрутираФаза 1
Возраст од 1 до 40 · Сите полови · Ажурирано 12.3.2026 · NCT05292664CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
Се регрутираФаза 2Добредојдени се здрави волонтери
Возраст од 18 до 75 · Сите полови · Ажурирано 10.3.2026 · NCT06059391Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- City of Hope Medical Center, Duarte
Се регрутираФаза 1
Возраст 2 и постари · Сите полови · Ажурирано 5.3.2026 · NCT06575296Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- City of Hope Medical Center, Duarte
Се регрутираФаза 2
Возраст од 10 до 30 · Сите полови · Ажурирано 4.12.2025 · NCT05194397Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- City of Hope, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.11.2025 · NCT04260022Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
Се регрутираФаза 2
Возраст од 2 до 22 · Сите полови · Ажурирано 31.10.2025 · NCT06128070Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
- Lucille Packard Children's Hospital, Palo Alto
Се регрутира
1 Day – 45 Days · Сите полови · Ажурирано 1.5.2025 · NCT03898596Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 15.4.2025 · NCT06462365Bright Ideas - CIN Feasibility Study
- Children's Hospital Los Angeles, Los Angeles
Се регрутира
Возраст од 4 до 18 · Сите полови · Ажурирано 31.1.2025 · NCT04929899Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
- Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles
Се регрутира
Возраст од 5 до 18 · Сите полови · Ажурирано 20.1.2025 · NCT06096272Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
Се регрутираФаза 1
Возраст од 1 до 21 · Сите полови · Ажурирано 6.12.2024 · NCT05476770Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.